Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof
AssigneeSanguibiotech AG
InventorsWolfgang Barnikol, Harald Potzschke
Life of this patent
Estimating the term…
Abstract
Artificial oxygen carrier composed of native or modified hemoglobins for direct biological or medical use, in which the oxygen binding site of the hemoglobin is provided with a protective ligand, preferably carbon monoxide, which does not have to be removed prior to use.
Claims9
A method of providing a biological system with oxygen comprising introducing into said biological system a storage-stable hemoglobin-based artificial oxygen carrier comprised of hemoglobin having oxygen binding sites wherein said oxygen binding sites are provided with a carbon monoxide ligand.
A method of regulating the rate of reactivation of carbon monoxide ligandized hemoglobin based artificial oxygen carriers which comprises applying said oxygen carriers to a biological system receiving a supporting gas or a breathing gas wherein said artificial oxygen carrier is comprised of hemoglobin having oxygen binding sites wherein said oxygen binding sites are occupied with a carbon monoxide ligand wherein the oxygen content of said supporting gas or said breathing gas of said biological system is varied.
Dependencies are inferred from the claim text.